Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...

Daily low-dose aspirin reduced the risk for colorectal cancer recurrence by roughly half in patients with mutations in the ...

Health guidelines now advise against the practice for most people, because it increases likelihood of brain and ...

Many Americans don't see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks ...

Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...

WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of ...

Opens in a new tab or window SAN FRANCISCO -- In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) recurrence, according to ...

Cancer risk was cut by half in patients with a mutation that makes them more susceptible Overall, aspirin patients were 55% less likely to have cancer recur than those taking a placebo WEDNESDAY ...